Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
KBR
KBR
$4.76B
| $37.7M | 0.07% |
1,935,924
-534,946
| -22% | -$9.58M |
|
352
SPX Corp
SPXC
$10.1B
| $37.5M | 0.07% |
2,055,473
+649,235
| +46% | +$12.7M |
|
353
PACCAR
PCAR
$68.3B
| $37.3M | 0.07% |
877,806
+83,904
| +11% | +$3.62M |
|
354
Welltower
WELL
$173B
| $37.3M | 0.07% |
568,649
+69,885
| +14% | +$5.01M |
|
355
Rithm Capital
RITM
$5.71B
| $37.3M | 0.07% |
2,446,783
+2,076,325
| +560% | +$34.4M |
|
|
DF
356
DELISTED
Dean Foods Company
DF
| $37.2M | 0.07% |
2,301,748
-897,700
| -28% | -$15.7M |
|
357
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
| $37.1M | 0.07% |
437,519
-10,266
| -2% | -$871K |
|
358
Home Depot
HD
$335B
| $37.1M | 0.07% |
333,752
-19,205
| -5% | -$2.15M |
|
359
H&R Block
HRB
$6.67B
| $37.1M | 0.07% |
1,249,834
+1,235,649
| +8,711% | +$38.8M |
|
360
Norwegian Cruise Line
NCLH
$7.84B
| $37M | 0.07% |
660,813
+380,166
| +135% | +$20.4M |
|
361
O-I Glass
OI
$1.11B
| $37M | 0.07% |
1,610,752
+688,962
| +75% | +$16.8M |
|
362
Equinor
EQNR
$100B
| $36.7M | 0.07% |
2,052,412
-2,793,459
| -58% | -$54M |
|
|
ZNGA
363
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $36.5M | 0.07% |
12,760,496
+6,401,240
| +101% | +$17.9M |
|
364
AutoZone
AZO
$48.9B
| $36.4M | 0.07% |
54,608
+54,494
| +47,802% | +$37.3M |
|
|
EMC
365
DELISTED
EMC CORPORATION
EMC
| $36.4M | 0.07% |
1,379,787
-3,160,510
| -70% | -$84.3M |
|
366
Landstar System
LSTR
$6.09B
| $36.3M | 0.07% |
542,467
+413,663
| +321% | +$26.9M |
|
367
SPDR Gold Trust
GLD
$156B
| $36.2M | 0.07% |
321,980
+203,185
| +171% | +$23.3M |
|
368
PG&E
PCG
$39.7B
| $36M | 0.07% |
732,800
+78,804
| +12% | +$4.1M |
|
369
Procter & Gamble
PG
$339B
| $36M | 0.07% |
459,541
-369,730
| -45% | -$29.8M |
|
370
SLB Ltd
SLB
$78.9B
| $35.9M | 0.07% |
416,129
+191,041
| +85% | +$17.2M |
|
|
PDCE
371
DELISTED
PDC Energy, Inc.
PDCE
| $35.9M | 0.07% |
668,427
-1,014,405
| -60% | -$57.3M |
|
|
PLL
372
DELISTED
PALL CORP
PLL
| $35.8M | 0.07% |
+287,407
| New | +$32.4M |
|
373
Waste Management
WM
$90.5B
| $35.7M | 0.07% |
770,951
+139,561
| +22% | +$7.02M |
|
|
HRC
374
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $35.7M | 0.07% |
657,180
+331,620
| +102% | +$17.2M |
|
375
ArcelorMittal
MT
$55B
| $35.6M | 0.07% |
1,600,164
+1,536,547
| +2,415% | +$37M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.